| Fund Name | Location |
| BeyondTrust | California, Carlsbad, United States |
| Dongfang Weixin Keji | China, Tianjin, Tianjin |
| Hicks Oilfield | - |
| Integrated Networks | Ar Riyad, Riyadh, Saudi Arabia |
| JMCR Partners | China, Hong Kong, Hong Kong Island |
| Johnsonville Sausage | United States, Watertown, Wisconsin |
| KKR & Co. | New York, New York, United States |
| Local Initiatives Support Corporation | New York, New York, United States |
| Magma Fincorp | India, Kolkata, West Bengal |
| Oppenheim Pramerica Asset Management | Luxembourg, Luxembourg |
| Piper Jaffray | Minneapolis, Minnesota, United States |
| Revelis Capital Group | Colorado, Denver, United States |
| Sanden | Gunma Prefecture, Isesaki, Japan |
| Shanghai Yijinghui Asset Management | China, Shanghai |
| StartVenture | California, San Francisco, United States |
| Suzhou Xiangtang Venture Capital | China, Jiangsu, Suzhou |
| Wanjia Gongying Zichan Guanli | China, Shanghai |
| Zhong Zao Weilai | Beijing, Beijing, China |
| Zhongqihui Venture Capital | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Caribou Biosciences | $115M | 03 Mar 2021 | United States, Berkeley |
– Ribon Therapeutics announced the closing of a $65m financing.
– The financing was led by Deerfield Management and U.S. Venture Partners, with support from new investors Avego BioScience Capital, GV (formerly Google Ventures), Monashee Investment Management and Peregrine Ventures, along with existing investors AbbVie Ventures, Bristol Myers Squibb, Euclidean Capital, Johnson & Johnson Innovation, Novartis Venture Fund, Osage University Partners, Takeda Ventures and The Column Group.
– Ribon will use the proceeds to support the clinical development of its novel precision medicine candidates.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Caribou Biosciences | $115M | 03 Mar 2021 | United States, Berkeley |
